IL17A and autoimmune polyendocrine syndrome type 1: Nevertheless, this observation provides near-experimental proof that auto-Abs neutralizing IL-17 cytokines can underlie CMC, and provides strong support for a role of auto-Abs against IL-17 cytokines in the onset of CMC in APS-1 patients126.